GAMMAGARD LIQUID
STN: BL 125105
Proper Name: Immune Globulin Infusion (Human)
Tradename: GAMMAGARD LIQUID
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
Indication:
- To improve neuromuscular disability and impairment in adult patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Product Information
Supporting Documents
- January 26, 2024 Approval Letter - GAMMAGARD LIQUID
- January 26, 2024 Clinical Review Memo - GAMMAGARD LIQUID
- Statistical Review - GAMMAGARD LIQUID
- Preclinical Pharmacology Toxicology Review - GAMMAGARD LIQUID
- Supporting Documents older than three years - Gammagard Liquid